The application of PDCA cycle in ADR teaching program and evaluation of its effect

Zhan-miao YI,Jing ZHANG,Xiao-xiao LI,Rong-sheng ZHAO
DOI: https://doi.org/10.3969/j.issn.1672-3384.2017.09.006
2017-01-01
Abstract:Objective: To explore the application of PDCA cycle in adverse drug reaction (ADR) teaching program and evaluate its effect. Methods: A PDCA cycle was designed specially according to the characteristics of ADR reporting. Intervention measures included problem-based and case-based ADR teaching program. A retrospective study of the ADR reports of the patients in an inpatient area of a third-grade class-A hospital was performed. Statistical and quality analysis of the ADR reports before and after intervention were conducted. SPSS19.0 was used for data analysis. Results: A total of 42 ADR reports were analyzed during the PDCA cycle. Two reports (accounting for 4.76% of the ADR reports during the PDCA cycle) were collected before the intervention, and both were ordinary ADRs reported by doctors. The number of excellent report was zero, and the consistent rate of relevance evaluation was also zero. After intervention, 40 reports (95.24%) were collected with an increase of 38 reports (90.50%). Ninety percent of the ADR cases were reported by pharmacists and pharmacy students, including 4 serious ADRs. The rate of excellent reports was 75.00%, and the consistent rate of relevance evaluation was 62.50%. Conclusion: ADR teaching program based on PDCA cycle can improve the number and quality of ADR reports, establish the pharmacovigilance system supported by doctors, nurses and pharmacists, and lay the foundation for safe and rational clinical drug use.
What problem does this paper attempt to address?